SARS-CoV-2 antigen-carrying extracellular vesicles activate T cell responses in a human immunogenicity model
Description
Extracellular vesicles (EVs) are entering the clinical arena as novel biologics for infectious diseases, potentially serving as the immunogenic components of next generation vaccines. However, relevant human assays to evaluate the immunogenicity of
